Meeting report: primary central nervous system lymphoma: standards of care and future perspectives.
A standard of care for patients with primary central nervous system lymphoma (PCNSL) has not been defined. Current controversies concern, amongst others, the role, dose and timing of radiotherapy, the role of intrathecal chemotherapy and the delineation of age-specific standards of care. Given the strong clinical trial activities for PCNSL in Germany, the PCNSL conference held in Tubingen aimed at comparing the diverging trial strategies in Germany and at exploring the options for joint activities of the various PCNSL study groups in the near future.
Herrlinger
Ulrich
U
Abteilung für Allgemeine Neurologie, Hertie-Institut für Klinische Hirnforschung, Zentrum für Neurologie, Universität Tübingen, Germany. ulrich.herrlinger@uni-tuebingen.de
Korfel
Agnieszka
A
Hebart
Holger
H
Schlegel
Uwe
U
Plasswilm
Ludwig
L
Illerhaus
Gerald
G
Finke
Jürgen
J
Krüger
William
W
Montemurro
Michael
M
Wolf
Timo
T
Thiel
Eckhart
E
Bamberg
Michael
M
Weller
Michael
M
Kanz
Lothar
L
D000970:Antineoplastic Agents / Q000145:classification / Q000592:standards / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005858:Germany; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000639:trends*; D016896:Treatment Outcome
D000970:Antineoplastic Agents